KRENSAVAGE ASSET MGT FORM 13G ENTA

Company

ENANTA PHARMACEUTICALS INC

Filed

February 15, 2017

Accession Number

0001609251-17-000004

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →